ACAD
27.08
-1.17
-4.14%
AEMD
4.8
+0.15
+3.23%
APRI
1.24
-0.05
-3.88%
ARNA
1.4
-0.08
-5.41%
ATEC
4.85
-0.07
-1.42%
CNAT
1.96
+0.04
+2.08%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.55
0.00
0.00%
DXCM
63.04
-2.44
-3.73%
GNMK
10.98
-0.26
-2.31%
HALO
11.31
-0.57
-4.80%
ILMN
122.02
-4.38
-3.47%
INNV
0.263
+0.003
+1.0769%
INO
6.97
-0.34
-4.65%
ISCO
1.31
+0.11
+9.17%
ISIS
0
0.00
0.00%
LGND
102.59
-3.28
-3.10%
LPTN
2.62
-0.06
-2.2351%
MBVX
4.06
+0.03
+0.74%
MEIP
1.54
-0.03
-1.91%
MNOV
7.58
-0.03
-0.39%
MRTX
5.35
+0.25
+4.90%
MSTX
0.083
+0.001
+1.7073%
NBIX
42.94
-2.09
-4.64%
NUVA
66.83
+0.2
+0.30%
ONCS
1.348
-0.002
-0.1778%
ONVO
3.09
-0.07
-2.22%
OREX
1.84
-0.1
-5.15%
OTIC
16.2
0.00
0.00%
QDEL
22.2
-0.03
-0.13%
RCPT
0
0.00
0.00%
RGLS
2.65
0.00
0.00%
RMD
60.34
+0.56
+0.94%
SCIE
0.002
0.00
-5.2632%
SPHS
2.74
-0.03
-1.08%
SRNE
5.2
-0.2
-3.70%
TROV
2.3
-0.2
-8.00%
VICL
2.34
+0.02
+0.86%
ZGNX
13
-0.25
-1.89%
ACAD
27.08
-1.17
-4.14%
AEMD
4.8
+0.15
+3.23%
APRI
1.24
-0.05
-3.88%
ARNA
1.4
-0.08
-5.41%
ATEC
4.85
-0.07
-1.42%
CNAT
1.96
+0.04
+2.08%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.55
0.00
0.00%
DXCM
63.04
-2.44
-3.73%
GNMK
10.98
-0.26
-2.31%
HALO
11.31
-0.57
-4.80%
ILMN
122.02
-4.38
-3.47%
INNV
0.263
+0.003
+1.0769%
INO
6.97
-0.34
-4.65%
ISCO
1.31
+0.11
+9.17%
ISIS
0
0.00
0.00%
LGND
102.59
-3.28
-3.10%
LPTN
2.62
-0.06
-2.2351%
MBVX
4.06
+0.03
+0.74%
MEIP
1.54
-0.03
-1.91%
MNOV
7.58
-0.03
-0.39%
MRTX
5.35
+0.25
+4.90%
MSTX
0.083
+0.001
+1.7073%
NBIX
42.94
-2.09
-4.64%
NUVA
66.83
+0.2
+0.30%
ONCS
1.348
-0.002
-0.1778%
ONVO
3.09
-0.07
-2.22%
OREX
1.84
-0.1
-5.15%
OTIC
16.2
0.00
0.00%
QDEL
22.2
-0.03
-0.13%
RCPT
0
0.00
0.00%
RGLS
2.65
0.00
0.00%
RMD
60.34
+0.56
+0.94%
SCIE
0.002
0.00
-5.2632%
SPHS
2.74
-0.03
-1.08%
SRNE
5.2
-0.2
-3.70%
TROV
2.3
-0.2
-8.00%
VICL
2.34
+0.02
+0.86%
ZGNX
13
-0.25
-1.89%
Home » Events

Label-Free Symposium

Submitted by on July 14, 2009 – 2:47 pm

Advances and challenges in label-free technologies for drug discovery

November 2-3, 2009

San Diego, CA

[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.

Please prove you\'re human, solve this: *
Time limit is exhausted. Please reload CAPTCHA.